JP2017509692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509692A5 JP2017509692A5 JP2016566866A JP2016566866A JP2017509692A5 JP 2017509692 A5 JP2017509692 A5 JP 2017509692A5 JP 2016566866 A JP2016566866 A JP 2016566866A JP 2016566866 A JP2016566866 A JP 2016566866A JP 2017509692 A5 JP2017509692 A5 JP 2017509692A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- patient
- dpp4
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931878P | 2014-01-27 | 2014-01-27 | |
| US61/931,878 | 2014-01-27 | ||
| US201461990932P | 2014-05-09 | 2014-05-09 | |
| US61/990,932 | 2014-05-09 | ||
| PCT/US2015/012885 WO2015112970A1 (en) | 2014-01-27 | 2015-01-26 | Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017509692A JP2017509692A (ja) | 2017-04-06 |
| JP2017509692A5 true JP2017509692A5 (enExample) | 2018-03-08 |
Family
ID=53682019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016566866A Pending JP2017509692A (ja) | 2014-01-27 | 2015-01-26 | 喘息肺におけるｉｌ−１３活性化の末梢バイオマーカーとしてのジペプチジルペプチターゼ４（ｄｐｐ４／ｃｄ２６） |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160363591A1 (enExample) |
| EP (2) | EP3685857A1 (enExample) |
| JP (1) | JP2017509692A (enExample) |
| KR (1) | KR20160113700A (enExample) |
| CN (1) | CN105934254A (enExample) |
| AU (1) | AU2015209124A1 (enExample) |
| BR (1) | BR112016017192A2 (enExample) |
| CA (1) | CA2937387A1 (enExample) |
| MX (1) | MX2016009491A (enExample) |
| RU (1) | RU2016134838A (enExample) |
| SG (1) | SG11201606102UA (enExample) |
| WO (1) | WO2015112970A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015214103A1 (en) * | 2014-02-07 | 2016-07-21 | Abbott Laboratories | Novel assay to detect human periostin |
| KR20170098941A (ko) | 2015-01-09 | 2017-08-30 | 메디뮨 엘엘씨 | 인간 dpp-4를 검출하기 위한 검정법 |
| JP2018538249A (ja) * | 2015-11-04 | 2018-12-27 | アストラゼネカ アクチボラグ | 好酸球性疾患における好酸球標的化治療薬に対する臨床応答の予測変数としてのジペプチジルペプチダーゼ−４およびペリオスチン |
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| JP6995844B2 (ja) * | 2016-09-23 | 2022-02-04 | ジェネンテック， インコーポレイテッド | アトピー性皮膚炎を治療するためのｉｌ－１３アンタゴニストの使用 |
| WO2018156734A1 (en) * | 2017-02-24 | 2018-08-30 | Trustees Of Boston University | Isolation of human lung progenitors derived from pluripotent stem cells |
| CN109055522A (zh) * | 2018-07-03 | 2018-12-21 | 吉林大学 | C4orf38在制备用于检测或治疗神经性疼痛的产品中的应用 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN113155996A (zh) * | 2021-03-23 | 2021-07-23 | 广州医科大学附属第一医院（广州呼吸中心） | 15(s)-羟基二十碳四烯酸在评估变应原特异性免疫治疗效果中的应用 |
| EP4540284A2 (en) | 2022-06-17 | 2025-04-23 | Apogee Therapeutics, Inc. | Antibodies that bind interleukin 13 and methods of use |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| EP1631680A2 (en) * | 2003-05-21 | 2006-03-08 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| CA2558366A1 (en) * | 2004-02-23 | 2005-09-01 | Erasmus Universiteit Rotterdam | Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling |
| BRPI0720280A2 (pt) * | 2006-12-11 | 2014-01-28 | Wyeth Corp | Métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13 |
| WO2008091814A2 (en) * | 2007-01-22 | 2008-07-31 | Wyeth | Assessment of asthma and allergen-dependent gene expression |
| US20120005206A1 (en) * | 2007-02-09 | 2012-01-05 | Konstantinos Anagnostakis | Apparatus and method for analysis of data traffic |
| CN102099485A (zh) * | 2007-10-23 | 2011-06-15 | 临床基因组学有限公司 | 诊断新生物的方法-ⅱ |
| RU2607569C2 (ru) | 2008-03-31 | 2017-01-10 | Дженентек, Инк. | Композиции и способы для лечения и диагностики астмы |
| US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| JP2013544235A (ja) * | 2010-10-15 | 2013-12-12 | メドイミューン・リミテッド | 肺機能を改善する治療法 |
| KR101615474B1 (ko) | 2010-12-16 | 2016-04-25 | 제넨테크, 인크. | Th2 억제에 관한 진단 및 치료 |
| US8961965B2 (en) | 2011-05-18 | 2015-02-24 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
-
2015
- 2015-01-26 KR KR1020167023637A patent/KR20160113700A/ko not_active Withdrawn
- 2015-01-26 EP EP20158832.4A patent/EP3685857A1/en not_active Withdrawn
- 2015-01-26 SG SG11201606102UA patent/SG11201606102UA/en unknown
- 2015-01-26 BR BR112016017192A patent/BR112016017192A2/pt not_active IP Right Cessation
- 2015-01-26 CA CA2937387A patent/CA2937387A1/en not_active Abandoned
- 2015-01-26 RU RU2016134838A patent/RU2016134838A/ru not_active Application Discontinuation
- 2015-01-26 JP JP2016566866A patent/JP2017509692A/ja active Pending
- 2015-01-26 EP EP15740660.4A patent/EP3099323A4/en not_active Withdrawn
- 2015-01-26 AU AU2015209124A patent/AU2015209124A1/en not_active Abandoned
- 2015-01-26 US US15/114,467 patent/US20160363591A1/en not_active Abandoned
- 2015-01-26 MX MX2016009491A patent/MX2016009491A/es unknown
- 2015-01-26 CN CN201580005884.2A patent/CN105934254A/zh active Pending
- 2015-01-26 WO PCT/US2015/012885 patent/WO2015112970A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017509692A5 (enExample) | ||
| O'Byrne et al. | Asthma progression and mortality: the role of inhaled corticosteroids | |
| Cao et al. | Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A | |
| Buhl et al. | Severe eosinophilic asthma: a roadmap to consensus | |
| RU2016134838A (ru) | Дипептидил пептидаза-4 (dpp4/cd26) как периферический биомаркер активации il-13 в астматическом легком | |
| Svenningsen et al. | Asthma endotypes and an overview of targeted therapy for asthma | |
| JP6457463B2 (ja) | 処置方法 | |
| de Groot et al. | Management of the patient with eosinophilic asthma: a new era begins | |
| Casale | Biologics and biomarkers for asthma, urticaria, and nasal polyposis | |
| Opina et al. | Phenotype-driven therapeutics in severe asthma | |
| EP2627673B1 (en) | Therapies for improving pulmonary function | |
| Geng et al. | Biologic therapies for allergic rhinitis and nasal polyposis | |
| JP2018533557A5 (enExample) | ||
| CN107073114B (zh) | 使用瑞利珠单抗治疗中度到重度嗜酸细胞性哮喘 | |
| JP2015028042A (ja) | 抗ｉｌ−５抗体を投与するための方法 | |
| Hvidtfeldt et al. | Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes | |
| Hong et al. | Mechanisms of corticosteroid resistance in type 17 asthma | |
| Yilmaz et al. | Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilicasthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study | |
| Tagaya et al. | Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD | |
| KR20240049348A (ko) | 항-인터루킨-33 항체를 사용한 만성 폐쇄성 폐질환의 치료 | |
| Pavord et al. | Emerging biologics in severe asthma | |
| US11224653B2 (en) | Treatment strategy for non-responders to 100MG subcutaneous mepolizumab | |
| Rupani et al. | Eosinophilic asthma | |
| Mastalerz et al. | Effect of inhaled corticosteroids on small airway inflammation in patients with bronchial asthma | |
| Moslem et al. | Evaluation of Effectiveness of Dexamethasone versus Hydrocortisone in Reducing Hospital Length, Peak Expiratory Flow, Oxidative Stress Factors and Inflammatory Mediators in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Patients: A Randomized Controlled Trial |